Elli Antypa
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 5
-
- Urinary Tract Infections Management 3
- Pneumonia and Respiratory Infections 1
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Inflammation biomarkers and pathways 1
-
- Erythropoietin and Anemia Treatment 1
-
- Lipid metabolism and disorders 1
-
- Vibrio bacteria research studies 1
- Co-authors
- Eleni AntoniadouKonstantinos Z. VardakasDimitrios K. MatthaiouMatthew E. FalagasΘωμάς ΤσαγανόςDespoina KoulentiApostolos ArmaganidisKonstantinos Mandragos
- Cited by
- Applied Microbiology and BiotechnologyMolecular MedicineCritical Care and Intensive Care Medicine
- Partner nations
- GreeceUnited States
In The Last Decade
Elli Antypa
8 papers receiving 151 citations
Peers
Comparison fields: 5 of 49
- Applied Microbiology and Biotechnology 31
- Molecular Medicine 59
- Critical Care and Intensive Care Medicine 21
- Epidemiology 78
- Clinical Biochemistry 15
Countries citing papers authored by Elli Antypa
This map shows the geographic impact of Elli Antypa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elli Antypa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elli Antypa more than expected).
Fields of papers citing papers by Elli Antypa
This network shows the impact of papers produced by Elli Antypa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elli Antypa. The network helps show where Elli Antypa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elli Antypa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 41 | |
| 2 | 2015 | 30 | |
| 3 | 2014 | 3 | |
| 4 | 2014 | 60 | |
| 5 | 2014 | 2 | |
| 6 | 2013 | 5 | |
| 7 | 2010 | 12 | |
| 8 | 2010 | 1 |
About Elli Antypa
Elli Antypa is a scholar working on Molecular Medicine, Developmental Neuroscience and Endocrinology, having authored 8 papers that have together received 154 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Urinary Tract Infections Management (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Inflammation biomarkers and pathways (1 paper), Erythropoietin and Anemia Treatment (1 paper), Lipid metabolism and disorders (1 paper), Pneumonia and Respiratory Infections (1 paper) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (31 citations), Molecular Medicine (59 citations) and Critical Care and Intensive Care Medicine (21 citations). Elli Antypa has collaborated with scholars based in Greece and United States. Frequent co-authors include Eleni Antoniadou, Konstantinos Z. Vardakas, Dimitrios K. Matthaiou, Matthew E. Falagas, Θωμάς Τσαγανός, Despoina Koulenti, Apostolos Armaganidis, Konstantinos Mandragos, Iraklis Tsangaris and N. Kapravelos. Their work appears in journals such as Critical Care, Clinical Microbiology and Infection and Cytokine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.